MIT Technology Review15h
The Download: HIV prevention shots, and fixing a broken sex doll
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
The Trump Administration Said These Aid Programs Saved Lives. It Canceled Them Anyway.
The axing of some 10,000 programs has consigned untold numbers of children and refugees to death, officials say. Documents ...
Healio7h
Gilead encouraged by data on once-yearly lenacapavir for HIV prevention
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
STAT13d
We tried to quantify the impact of abrupt PEPFAR cuts. The results startled even us
A peer reviewer questioned the premise of our study into the potential impact of abruptly ending PEPFAR funding. Then it ...
Clinical Trials Arena on MSN2d
Gilead to launch Phase III once-yearly HIV PrEP trial after Phase I success
Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...
Physician's Weekly8d
For Older Women With HIV, Gaps in Diagnosis & Care Drive Outcomes
Older women with HIV face complex, intersectional challenges that warrant more support, according to a scoping review with ...
News Medical on MSN2d
Gaps in HPV cancer screening and prevention identified for people living with HIV
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
The Scientist2d
Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...